SYK
HealthcareStryker Corporation
$348.79
+$0.61 (+0.18%)
Jan 5, 2026
Price History (1Y)
Analysis
Stryker Corporation is a leading healthcare company operating in the medical devices sector. With a market capitalization of $133.39B, it has substantial scale and presence in its industry. The company employs approximately 53,000 individuals globally. From a financial perspective, Stryker's profitability metrics indicate a solid foundation. The company maintains a gross margin of 65.0%, operating margin of 22.3%, and profit margin of 12.1%. In terms of returns on equity (ROE) and assets (ROA), the firm reports ROE of 14.0% and ROA of 7.5%. Additionally, its balance sheet shows a debt-to-equity ratio of 78.65 and a current ratio of 1.85. Cash reserves total $3.34B, while outstanding debt stands at $17.13B. Valuation metrics provide context for Stryker's financial performance. The company's price-to-earnings (P/E) ratio is 45.65 on a trailing twelve-month basis and 23.34 forward. Revenue growth has been steady, with a year-over-year increase of 10.2%. Earnings growth, however, has been lower at 2.8% YoY. Dividend yield stands at 101.0%, with a payout ratio of 44.1%.
This analysis is AI-generated for informational purposes only and should not be considered financial advice. Data may be delayed or inaccurate. Always do your own research and consult a qualified financial advisor before making investment decisions.
About Stryker Corporation
Stryker Corporation operates as a medical technology company. It operates through two segments, MedSurg and Neurotechnology, and Orthopaedics. The MedSurg and Neurotechnology segment offers surgical equipment, and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, clinical communication and artificial intelligence-assisted virtual care platform technology, minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke, cranial, and maxillofacial and chest wall devices, as well as dural substitutes and sealants; traditional brain and open skull based surgical procedures products; and orthobiologic and biosurgery products, including synthetic bone grafts and vertebral augmentation products. The Orthopaedics segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries; thoracolumbar systems that include fixation, minimally invasive and interbody systems used in spinal injury, complex spine and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Portage, Michigan.
Visit website →Key Statistics
- Market Cap
- $133.39B
- P/E Ratio
- 45.65
- 52-Week High
- $406.19
- 52-Week Low
- $329.16
- Avg Volume
- 1.63M
- Beta
- 0.90
- Dividend Yield
- 101.00%
Company Info
- Industry
- Medical Devices
- Exchange
- NYQ
- Country
- United States
- Employees
- 53,000